Posted in | News | Mining Business

Seabridge Gold Announces Filing of Preliminary Shelf Prospectus and Corresponding Registration Statement

Seabridge Gold Inc. (the "Company") announced today that it has filed a preliminary short form base shelf prospectus with the securities commissions in each of the Provinces of Ontario, Alberta and British Columbia and a corresponding registration statement on Form F-10 with the United States Securities and Exchange Commission (SEC).

Seabridge Chairman and CEO Rudi Fronk commented that: "Following the closing this week of our $13.8 million financing, we do not currently have any plans to arrange additional funding. The purpose of this shelf prospectus is to give us greater flexibility should additional funding be required in the future. The dollar limit noted in the filing does not reflect a considered estimate of future financing requirements, which will depend upon future developments and are unknowable at this time."

The shelf prospectus filings, when final, will allow Seabridge to make offerings of common shares up to an aggregate total of Cdn$100 million during the 25-month period that the final short form base shelf prospectus remains effective. Common shares may be offered in amounts, at prices and on terms to be determined based on market conditions at the time of sale and set forth in one or more shelf prospectus supplements and, subject to applicable regulations, may include at-the-market transactions, public offerings or strategic investments. The net proceeds from any sale of the common shares will be used for general corporate purposes, including funding future exploration and development work on the Company's two material assets, the KSM Project and the Courageous Lake Project. More detailed information regarding the use of proceeds from a sale of common shares will be included in the applicable prospectus supplement.

A copy of the preliminary short form base shelf prospectus, the final short form base shelf prospectus and any shelf prospectus supplements that may be filed in the future, can be found on SEDAR at www.sedar.com and on EDGAR at www.sec.gov or may be obtained by request to the Assistant Corporate Secretary, Seabridge Gold Inc., 106 Front Street East, Suite 400, Toronto, Ontario, M5A 1E1, Canada (Telephone: 1-416-367-9292)

Seabridge holds a 100% interest in several North American gold resource projects. The Company's principal assets are the KSM property located near Stewart, British Columbia, Canada and the Courageous Lake gold project located in Canada's Northwest Territories. For a breakdown of Seabridge's mineral reserves and resources by project and category please visit the Company's website at http://www.seabridgegold.net/resources.php.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Seabridge Gold Inc.. (2022, July 11). Seabridge Gold Announces Filing of Preliminary Shelf Prospectus and Corresponding Registration Statement. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=10227.

  • MLA

    Seabridge Gold Inc.. "Seabridge Gold Announces Filing of Preliminary Shelf Prospectus and Corresponding Registration Statement". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=10227>.

  • Chicago

    Seabridge Gold Inc.. "Seabridge Gold Announces Filing of Preliminary Shelf Prospectus and Corresponding Registration Statement". AZoMining. https://www.azomining.com/News.aspx?newsID=10227. (accessed November 21, 2024).

  • Harvard

    Seabridge Gold Inc.. 2022. Seabridge Gold Announces Filing of Preliminary Shelf Prospectus and Corresponding Registration Statement. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=10227.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.